Wouter Joustra - 18 Dec 2025 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Director
Signature
/s/ Adi Osovsky, Attorney-in-Fact
Issuer symbol
VOR
Transactions as of
18 Dec 2025
Transactions value $
$0
Form type
4
Filing time
19 Dec 2025, 18:17:24 UTC
Previous filing
16 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Joustra Wouter Director C/O VOR BIOPHARMA INC., 500 BOYLSTON STREET, SUITE 1350, BOSTON /s/ Adi Osovsky, Attorney-in-Fact 19 Dec 2025 0001897813

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VOR Stock Option (Right to Buy) Award $0 +3K $0.00 3K 18 Dec 2025 Common Stock 3K $12.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares shall vest and become exercisable in a series of 36 successive equal monthly installments beginning on December 18, 2025, in each case subject to the Reporting Person's continued service as of each such date.